Guardian Pharmacy Services (GRDN) Depreciation & Amortization (CF) (2023 - 2026)

Guardian Pharmacy Services (GRDN) has 4 years of Depreciation & Amortization (CF) data on file, last reported at $6.0 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 13.46% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.0 million (up 13.58% YoY) and the FY2025 annual result came in at $22.3 million, up 12.96% from the prior year.
• Depreciation & Amortization (CF) climbed to $6.0 million in Q1 2026 per GRDN's latest filing, from $5.7 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $6.0 million in Q1 2026, with the low at $4.7 million in Q4 2023.
• Average Depreciation & Amortization (CF) over 4 years is $5.3 million, with a median of $5.2 million recorded in 2024.
• Year-over-year, Depreciation & Amortization (CF) increased 9.31% in 2024 and climbed 16.9% in 2025.
• Guardian Pharmacy Services' Depreciation & Amortization (CF) stood at $4.7 million in 2023, then advanced by 9.31% to $5.2 million in 2024, then grew by 11.41% to $5.7 million in 2025, then grew by 4.09% to $6.0 million in 2026.
• Business Quant data shows GRDN's Depreciation & Amortization (CF) at $6.0 million in Q1 2026, $5.7 million in Q4 2025, and $5.8 million in Q3 2025.